Quick answers
- What is Ursolign?
- Ursolign is a brand name of Ursodiol, a prescription medicine. The FDA NDC Directory lists 1 Ursolign product in 1 strength and form.
- Who makes Ursolign?
- Strides Pharma holds the FDA application for Ursolign (ANDA210344, approved January 22, 2021).
- Is there a generic or store brand of Ursolign?
- Other products of Ursodiol are listed with the FDA, but none in exactly the same strength and form as a Ursolign product.
- Has Ursolign been recalled?
- No recall linked to Ursolign products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Ursolign is
Each Ursolign product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Ursodiol · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ursodiol 150 mg capsule (oral) | Ursolign | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ursodiol →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA210344 | Strides Pharma | January 22, 2021 | 1 |
Companies that list Ursolign
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Ursolign products.
- Pangea Pharmaceuticals, LLC1 product
Recalls
No recall linked to Ursolign products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.